SPECIAL OFFER : 25% Super Discount For All !
Global Protease Inhibitors Market, By Mechanism of Action (Serine Protease Inhibitors, Cysteine Protease Inhibitors, Amino Peptidase Inhibitor, Aspartic Protease Inhibitors, Metalloprotease Inhibitors, and Others), By Application (Commodity Protease Inhibitor, Research Tool Protease Inhibitor, And Protease Inhibitor Drugs), By End-Use (Hospitals & Diagnostic Centers, Pharmaceutical Industries, And Academic & Research Institutes), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2020-2026
- Published Date: November 2020
- Report ID: BWC20206
- Available Format: PDF
- Page: 182
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Protease Inhibitors Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Recent Development
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Intensity of Rivalry
4.5. Impact of Covid-19 on Protease Inhibitors Industry
5. Global Protease Inhibitors Market Overview
5.1. Market Size & Forecast by Value, 2016-2026
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Mechanism of action
5.2.1.1. Serine protease inhibitors
5.2.1.2. Cysteine protease inhibitors
5.2.1.3. Amino peptidase inhibitor
5.2.1.4. Aspartic protease inhibitors
5.2.1.5. Metalloprotease inhibitors
5.2.1.6. Others
5.2.2. By Application
5.2.2.1. Commodity protease inhibitor
5.2.2.2. Research tool protease inhibitor
5.2.2.3. Protease inhibitor drugs
5.2.2.4. Others
5.2.3. By End-User
5.2.3.1. Hospitals & diagnostic centers
5.2.3.2. Pharmaceutical industries
5.2.3.3. Academic
5.2.3.4. Research institutes
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia Pacific
5.2.4.4. Latin America
5.2.4.5. Middle East & Africa
6. North America Protease Inhibitors Market
6.1. Market Size & Forecast by Value, 2016-2026
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Mechanism of action
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. United States
6.2.4.2. Canada
7. Europe Protease Inhibitors Market
7.1. Market Size & Forecast by Value, 2016-2026
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Mechanism of action
7.2.2. By Application
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. Italy
7.2.4.3. France
7.2.4.4. United Kingdom
7.2.4.5. Spain
7.2.4.6. Rest of Europe
8. Asia Pacific Protease Inhibitors Market
8.1. Market Size & Forecast by Value, 2016-2026
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Mechanism of action
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of Asia Pacific
9. Latin America Protease Inhibitors Market
9.1. Market Size & Forecast by Value, 2016-2026
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Mechanism of action
9.2.2. By Application
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Mexico
9.2.4.3. Rest of Latin America
10. Middle East & Africa Protease Inhibitors Market
10.1. Market Size & Forecast by Value, 2016-2026
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Mechanism of action
10.2.2. By Application
10.2.3. By End-User
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. Egypt
10.2.4.3. Qatar
10.2.4.4. UAE
10.2.4.5. GCC
10.2.4.6. Rest of Middle East & Africa
11. Competitive Landscape
11.1.List of Key Players and Their Offerings
11.2.Market/Ranking Share Analysis
11.3.Competitive Benchmarking, By Operating Parameters
12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
12.1. Thermo Fisher Scientific Inc.
12.2. Sigma-Aldrich, Inc.
12.3. CYTOSKELETON, INC.
12.4. Merck & Co., Inc.
12.5. Genentech, Inc.
12.6. Boehringer Ingelheim International GmbH
12.7. AbbVie Inc.
12.8. Bristol-Myers Squibb Company
12.9. Janssen Pharmaceutical Companies
12.10. GlaxoSmithKline plc
12.11. Vertex Pharmaceuticals
12.12. CSL Behring LLC.
12.13. Takeda Pharmaceutical Company Limited
12.14. Pharming Technologies B.V.
12.15. KalVista Pharmaceuticals, Inc
12.16. BioCryst Pharmaceuticals
12.17. Ionis Pharmaceuticals, Inc.
12.18. Centogene AG
12.19. Other prominent players
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.